Skip to main content
FDA OKs combo therapy of niraparib, abiraterone acetate for prostate cancer
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA OKs combo therapy of niraparib, abiraterone acetate for prostate cancer
User login
Username
Password
Reset your password
Concept
Lead
score
Prostate Cancer
1
1
Breast Cancer
0
0.9
Ovarian Cancer
0
0.96
BRCA
0
0.59
Cancer
0
0.59
Prostate
0
0.52
Biologic Therapy
0
0.44
Genomic Medicine
0
0.37
Toxicology
0
0.37
Constipation
0
0.07
Fatigue
0
0.07
Hypertension
0
0.07
Nausea
0
0.07
Pain
0
0.07
Pain Management
0
0.07
Poly ADP-Ribose Polymerase (PARP) Inhibitor
0
0.07
Precision Medicine
0
0.07
Prognosis
0
0.07
Tissue
0
0.07
Specialty
Lead
score
Hematology-Oncology
1
1
Urology
0
0.9
Edit Tags